Trial · NCT07052084
Systematic Adjunction of Vasopressine in Septic Shock
NCT07052084, Phase 3, Recruiting, Assistance Publique Hopitaux De Marseille
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Systematic Adjunction of Vasopressine in Septic Shock. Trials, record NCT07052084. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07052084
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Systematic Adjunction of Vasopressine in Septic Shock
- NCT number
- NCT07052084
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Conditions
- Septic Shock
- Interventions
- Vasopressin administration, Sodium chloride administration
- First posted
- 2025-07-04
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | SOFA score comparison between the two groups | 48 hours after administration of experimental drug (H48) | Sepsis-related Organ Failure Assessment, 0 to 24 points (higher scores indicate more severe organ dysfunction) |
| Secondary | SOFA score comparison between the two groups | 120 hours after administration of experimental drug (H120) | Sepsis-related Organ Failure Assessment, 0 to 24 points (higher scores indicate more severe organ dysfunction) |
| Secondary | Mortality comparison between the two groups | 28 days after administration of experimental drug (D28) | |
| Secondary | Lactatemia decrease comparison between the two groups | Between administration of experimental drug (H0), 24 hours after (H24), and 48 hours after (H48) | |
| Secondary | Noradrenaline use comparison between the two groups | 5 days after administration of experimental drug (D5) | Maximum dose |
| Secondary | Renal function comparison between the two groups | 28 days after administration of experimental drug (D28) | Number of days alive without renal replacement therapy |
| Secondary | Respiratory function comparison between the two groups | 28 days after administration of experimental drug (D28) | Number of days alive without mechanical ventilation |
| Secondary | Occurrence of myocardial ischemia comparison between the two groups | 28 days after administration of experimental drug (D28) | |
| Secondary | Occurrence of cardiogenic shock comparison between the two groups | 28 days after administration of experimental drug (D28) | |
| Secondary | Occurrence of mesenteric ischemia comparison between the two groups | 28 days after administration of experimental drug (D28) |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07052084
GET https://conductscience.org/api/trials/v1/NCT07052084/registered